Global Edition news

By Laura Lovett November 19, 2018
On Friday, New York-based startup Renalytix AI, maker of a clinical diagnostic that uses artificial intelligence to diagnose for kidney disease, landed $29 million in funding. This news coincides with Renalytix AI’s announcement that it will now be publicly traded on the London Stock Exchange.  Looking ahed, the company said the new money will be used to help it develop two products designed for...
By Dave Muoio November 19, 2018
The FDA is seeking public comments for a proposed framework that would allow the majority of apps and software released by pharmas that accompany a drug treatment to avoid lengthy premarket review submissions. According to a notice released last week, such software would be viewed as “promotional labeling,” and therefore only require submission to the FDA’s Office of Prescription Drug Promotion (...
By Babyforyou.net.ua November 16, 2018
Health 2.0 has two exciting opportunities for digital health startups coming up at the beginning of 2019, and the time to apply for both is now. First off, on January 7th in San Francisco — concurrent with JP Morgan Week — is Health 2.0 VentureConnect Top 20 Tech Showcase. Health2.0 VentureConnect will bring together top tech startups, venture capitalists, entrepreneurs, policy makers and more...
By Jonah Comstock November 16, 2018
Four years after announcing an ambitious — and often ridiculed — project to create a glucose-sensing lens along with Novartis subsidiary Alcon, Alphabet's Verily is throwing in the towel, the company announced in a blog post today. It will continue to work on two other medical lens projects, aimed at presbyopia and cataract surgery recovery. "Our clinical work on the glucose-...
By Dave Muoio November 15, 2018
Every day sees strides across the field of artificial intelligence, and healthcare is just one of the many industries looking to smart automation as a means to reduce burden and improve results. The last year in particular has brought a wealth of new healthcare focused software tools to the forefront, and as such has ignited debate on how these algorithms are being reviewed and regulated by the...
By Jonah Comstock November 15, 2018
Belgian biopharma company UCB has tapped customer engagement company Verint Systems to create an app for patients with Parkinson's disease. The app is called PD Coach and includes an AI assistant named April which can communicate with users either by text or speech. At launch, the app will support journaling and symptoms tracking. April is programmed with a wealth of Parkinson's-specific...
By Jonah Comstock November 15, 2018
On its third quarter earnings call last week, Dexcom recapped a busy Q3 — of note, one that included the acquisition of TypeZero Technologies for $11.3 million in August as well as two new FDA clearances in October and November. One of these clearances was for a new mobile app interface for the Dexcom G6 while the other was the Dexcom Pro Q CGM, a new disposable glucose monitoring device intended...
By Dave Muoio November 15, 2018
Tattoo circuits. Researchers from Carnegie Mellon University and the University of Coimbra have unveiled a method of printing thin circuits that could better enable wearable computation. The low-cost alloy is attached to a stretchable tattoo paper that adheres to the skin when wet, similarly to the decorative tattoos worn by children. "This is a breakthrough in the printed electronics area,"...
By Jonah Comstock November 14, 2018
Computer vision has great promise for helping to democratize fields like wound care, dermatology and more. However, as companies explore this potential, they’re also discovering a number of challenges to overcome. The data problem “Getting the data is really the biggest challenge, not the AI,” Karen Panetta, IEEE fellow and dean of graduate engineering at Tufts University who studies AI use cases...
By Dave Muoio November 14, 2018
De Novo clearance for urinary incontinence wearable. The FDA has granted De Novo clearance to Atlantic Therapeutics’ Innovo therapy device, an externally worn electrical muscle stimulator for the treatment of stress urinary incontinence. The wearable is intended for adult women as a front-line or second-line therapy, and in a multi-center randomized controlled trial recorded an 87 percent rate of...

Editor's Pick